MBIO Insider Trading Activity and SEC Form 4 Filings
MBIO insider trading summary
No open-market insider purchases or sales of Mustang Bio, Inc. (MBIO) have been reported on SEC Form 4 in the past 12 months.
Latest MBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 13, 2022 | Lindsay A Md Rosenwald | Director | Buy | $3K (5,000 @ $0.52) |
| Sep 13, 2022 | Manuel MD Litchman | Director | Buy | $3K (5,000 @ $0.52) |
| Mar 18, 2022 | Manuel MD Litchman | Director | Buy | $4K (5,000 @ $0.74) |
| Mar 18, 2022 | Lindsay A Md Rosenwald | Director | Buy | $3K (4,094 @ $0.74) |
| Dec 14, 2021 | Brian Achenbach | SVP, Fin. & Corp. Controller | Sell | $8K (4,374 @ $1.83) |
| Oct 27, 2021 | Manuel MD Litchman | President and CEO | Buy | $146K (65,000 @ $2.24) |
| Oct 12, 2021 | Brian Achenbach | SVP, Fin. & Corp. Controller | Sell | $10K (4,450 @ $2.28) |
| Jul 30, 2021 | Manuel MD Litchman | President and CEO | Buy | $251K (86,206 @ $2.91) |
| Apr 9, 2021 | Brian Achenbach | SVP, Fin. & Corp. Controller | Sell | $8K (2,423 @ $3.36) |
| Mar 5, 2021 | Manuel MD Litchman | President and CEO | Buy | $517K (165,562 @ $3.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.